These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3552317)

  • 1. Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far.
    Packer M; Kessler PD; Lee WH
    Circulation; 1987 Jun; 75(6 Pt 2):V56-64. PubMed ID: 3552317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of heart failure with calcium antagonists].
    Hall D; Dirschinger J; Kraus F; Rudolph W
    Herz; 1990 Jun; 15(3):179-84. PubMed ID: 2198218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of calcium antagonists in the pharmacologic treatment of heart insufficiency].
    de Sá ME
    Rev Port Cardiol; 1989; 8(7-8):547-52. PubMed ID: 2698718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failure.
    Packer M
    Circulation; 1989 Dec; 80(6 Suppl):IV59-67. PubMed ID: 2688986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel blockers for heart rate control in atrial fibrillation complicated by congestive heart failure.
    Heywood JT
    Can J Cardiol; 1995 Oct; 11(9):823-6. PubMed ID: 7585281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving role of calcium channel blockers in heart failure.
    Pieper JA
    Pharmacotherapy; 1996; 16(2 Pt 2):43S-49S. PubMed ID: 8668605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists in heart failure.
    Klugmann S; Salvi A; Camerini F
    Herz; 1983 Apr; 8(2):88-92. PubMed ID: 6852766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcium channel blockers in heart failure].
    Hole T; Dickstein K; Gundersen T; Kjekshus J; Myhre ES; Rønnevik PK; Westheim AS
    Tidsskr Nor Laegeforen; 1997 Jun; 117(16):2329-32. PubMed ID: 9265278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congestive heart failure in patients with normal left ventricular systolic function: a manifestation of diastolic dysfunction.
    Gaasch WH
    Herz; 1991 Feb; 16(1):22-32. PubMed ID: 1673955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical therapy and prognosis in chronic heart failure. Lessons from clinical trials.
    Ramahi TM; Lee FA
    Cardiol Clin; 1995 Feb; 13(1):5-26. PubMed ID: 7796432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists and heart failure. Critical review of the literature].
    Devigili G
    Minerva Cardioangiol; 1994 Apr; 42(4):177-89. PubMed ID: 8058185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicardipine in heart failure: distinguishing its acute beneficial from its chronic effects.
    Sy J; Vitarelli A; Gheorghiade M
    Minerva Cardioangiol; 1993 Nov; 41(11):535-41. PubMed ID: 8127455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of calcium-entry blockade on left ventricular systolic and diastolic function.
    Walsh RA
    Circulation; 1987 Jun; 75(6 Pt 2):V43-55. PubMed ID: 3552316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term hemodynamic effects of mibefradil in dogs with chronic heart failure: comparison with diltiazem.
    Shimoyama H; Sabbah HN; Tanimura M; Borzak S; Goldstein S
    J Pharmacol Exp Ther; 1998 May; 285(2):746-52. PubMed ID: 9580622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New knowledge on the subject of therapy in cardiac decompensation in the light of large trials].
    Camerini F; Perkan A; Sinagra G; Di Lenarda A; Pinamonti B; Zecchin M
    Ann Ital Med Int; 1994 Oct; 9 Suppl():68S-77S. PubMed ID: 7857761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium antagonists in the treatment of heart failure. Re-evaluation of therapeutic strategies].
    Gattis W; O'Connor CM
    Drugs; 2000; 59 Spec No 2():17-24. PubMed ID: 11002855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
    Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blockers in congestive heart failure: theoretic considerations and clinical experience.
    Colucci WS; Fifer MA; Lorell BH; Wynne J
    Am J Med; 1985 Feb; 78(2B):9-17. PubMed ID: 3976695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
    Olivari MT; Levine TB; Cohn JN
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of calcium antagonists in the management of congestive heart failure: initial experience with lacidipine.
    de Vries RJ; Dunselman PH
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S33-9. PubMed ID: 8852543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.